Skip to main content
TipRanks
Go Ultimate75% OFF

Galectin Therapeutics (GALT) Balance Sheet

683 Followers

Galectin Therapeutics Balance Sheet

Galectin Therapeutics's total assets for Q3 2026 were $13.01M, a decrease of 12.26% from the previous quarter. GALT total liabilities were $46.45M for the fiscal quarter, a 69.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetMar 26Mar 25Dec 23Dec 22Mar 22
$ 19.53M$ 17.50M$ 28.20M$ 21.29M$ 41.83M
$ 145.73M$ 120.56M$ 88.44M$ 53.48M$ 39.21M
$ -126.19M$ -103.07M$ -60.24M$ -32.19M$ 2.62M

Currency in USD

Galectin Therapeutics Liabilities to Assets

060M120M180M0 %300 %600 %900 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets